Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHIYANKUSUBIRU CORP ENU BUI
Original Assignee
SHIYANKUSUBIRU CORP ENU BUI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHIYANKUSUBIRU CORP ENU BUIfiledCriticalSHIYANKUSUBIRU CORP ENU BUI
Priority to JP58103570ApriorityCriticalpatent/JPS59231020A/ja
Publication of JPS59231020ApublicationCriticalpatent/JPS59231020A/ja
Publication of JPH0520415B2publicationCriticalpatent/JPH0520415B2/ja
Nouveaux medicaments anticancereux pour le traitement des leucemies t constitues de la chaine a de la ricine et d'un anticorps monoclonal specifique